Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients.

Tytuł:
Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients.
Autorzy:
Kristo I; Department of Surgery, Upper GI Research and Service, Comprehensive Cancer Center, Gastroesophageal Tumor Unit, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Paireder M; Department of Surgery, Upper GI Research and Service, Comprehensive Cancer Center, Gastroesophageal Tumor Unit, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Jomrich G; Department of Surgery, Upper GI Research and Service, Comprehensive Cancer Center, Gastroesophageal Tumor Unit, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Felsenreich DM; Department of Surgery, Metabolic & Bariatric Surgery, Medical University of Vienna, Vienna, Austria.
Nikolic M; Department of Surgery, Upper GI Research and Service, Comprehensive Cancer Center, Gastroesophageal Tumor Unit, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Langer FB; Department of Surgery, Metabolic & Bariatric Surgery, Medical University of Vienna, Vienna, Austria.
Prager G; Department of Surgery, Metabolic & Bariatric Surgery, Medical University of Vienna, Vienna, Austria.
Schoppmann SF; Department of Surgery, Upper GI Research and Service, Comprehensive Cancer Center, Gastroesophageal Tumor Unit, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .
Źródło:
Obesity surgery [Obes Surg] 2019 Nov; Vol. 29 (11), pp. 3536-3541.
Typ publikacji:
Historical Article; Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: 2006- : New York : Springer Science + Business Media
Original Publication: Oxford, OX, UK : Rapid Communications of Oxford, [1991-
MeSH Terms:
Diagnostic Techniques, Digestive System*/history
Diagnostic Techniques, Digestive System*/trends
Manometry*/history
Manometry*/methods
Esophagus/*physiology
Gastroesophageal Reflux/*complications
Gastroesophageal Reflux/*diagnosis
Obesity, Morbid/*complications
Adult ; Esophageal Motility Disorders/epidemiology ; Esophageal Motility Disorders/etiology ; Esophageal Motility Disorders/physiopathology ; Esophageal pH Monitoring ; Female ; Gastroesophageal Reflux/epidemiology ; Gastroesophageal Reflux/physiopathology ; History, 21st Century ; Humans ; Male ; Middle Aged ; Obesity, Morbid/diagnosis ; Obesity, Morbid/epidemiology ; Obesity, Morbid/physiopathology ; Prevalence ; Sensitivity and Specificity
References:
J Clin Gastroenterol. 2003 Sep;37(3):206-15. (PMID: 12960718)
Digestion. 2017;95(1):29-35. (PMID: 28052278)
Eur J Gastroenterol Hepatol. 1996 Jul;8(7):635-40. (PMID: 8853250)
Obes Surg. 1999 Aug;9(4):390-5. (PMID: 10484299)
N Engl J Med. 2017 Feb 16;376(7):641-651. (PMID: 28199805)
Obes Surg. 2018 Nov;28(11):3586-3594. (PMID: 30047101)
Obes Surg. 2002 Feb;12(1):72-6. (PMID: 11868303)
Obes Surg. 2004 Jun-Jul;14(6):744-9. (PMID: 15318976)
Surg Obes Relat Dis. 2018 Jun;14(6):764-768. (PMID: 29631982)
Gut. 2018 Jul;67(7):1351-1362. (PMID: 29437910)
Dig Dis Sci. 1999 Nov;44(11):2290-4. (PMID: 10573376)
Gastroenterology. 2007 Mar;132(3):883-9. (PMID: 17324403)
Neurogastroenterol Motil. 2015 Feb;27(2):160-74. (PMID: 25469569)
Dig Dis Sci. 1995 Aug;40(8):1632-5. (PMID: 7648961)
Lancet Neurol. 2017 Jun;16(6):465-477. (PMID: 28504110)
J Med. 1987;18(3-4):135-46. (PMID: 3480930)
J Gastrointest Surg. 2009 Dec;13(12):2219-25. (PMID: 19672666)
Gut. 1999 Aug;45(2):172-80. (PMID: 10403727)
Sci Rep. 2018 Jul 2;8(1):9949. (PMID: 29967357)
Surg Endosc. 2019 Mar;33(3):789-793. (PMID: 30003346)
J Gastroenterol Hepatol. 2016 Jun;31(6):1133-40. (PMID: 26670865)
Obes Surg. 2016 Oct;26(10):2449-56. (PMID: 26956879)
Neurogastroenterol Motil. 2017 Mar;29(3):. (PMID: 27660053)
Endosc Int Open. 2016 May;4(5):E585-8. (PMID: 27274539)
J Thorac Dis. 2017 May;9(5):E432-E436. (PMID: 28616302)
Lancet. 2014 Aug 30;384(9945):766-81. (PMID: 24880830)
Obes Surg. 2018 Feb;28(2):313-322. (PMID: 28822052)
JAMA. 1999 Oct 27;282(16):1523-9. (PMID: 10546691)
Obes Surg. 2004 Aug;14(7):959-66. (PMID: 15329186)
Neurogastroenterol Motil. 2018 May;30(5):e13276. (PMID: 29266608)
Contributed Indexing:
Keywords: Gastroesophageal reflux disease; Morbidly obese; Motility disorders
Entry Date(s):
Date Created: 20190616 Date Completed: 20200526 Latest Revision: 20210109
Update Code:
20240105
DOI:
10.1007/s11695-019-04020-1
PMID:
31201693
Czasopismo naukowe
Background: The implementation of high-resolution manometry (HRM) and the Lyon Consensus statement facilitate evaluation of gastroesophageal reflux disease and motility disorders in morbidly obese patients. Therefore, we aimed to investigate prevalence and phenotype of (borderline) GERD and esophageal motility disorders in this population.
Methods: Consecutive morbidly obese (BMI ≥ 35 kg/m 2 ) patients were offered evaluation by means of HRM, ambulatory 24-h pH impedance monitoring, endoscopy, and a clinical examination at our tertiary academic center. Data were collected prospectively.
Results: Out of 448 eligible individuals, 147 patients (females = 75, 51%) with a median age of 41.6 (33.4; 52.3) years and a BMI of 44 (40.9; 49.4) kg/m 2 were included during the study period. The Chicago Classification revealed motility disorders in 50 (34%) patients, dominated by outflow obstruction (18.4%, n = 27) and a novel disorder (7.5%, n = 11), nicknamed jackhammer esophagus (JE). According to the Lyon Consensus, 52 (35.4%) patients had evidence of true GERD, whereas borderline GERD was noted in another 60 (40.8%). Hypersensitive esophagus was observed in 6.8% (n = 10). Sensitivity and specificity of symptoms for GERD were 53.8% and 68.4%, respectively.
Conclusions: The current gold standard of assessment revealed that the prevalence of esophageal motility disorders and (borderline) GERD is high in the morbidly obese population. Further longitudinal data are needed to delineate the natural course of novel motility disorders like JE in obesity and to identify risk factors for adverse outcomes following bariatric surgery.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies